A future approach to measuring relative skin sensitising potency: a proposal
- 13 June 2006
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 26 (4), 341-350
- https://doi.org/10.1002/jat.1146
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor alphaThe Journal of Immunology, 2018
- Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergenToxicology and Applied Pharmacology, 2005
- Development of a Peptide Reactivity Assay for Screening Contact AllergensToxicological Sciences, 2004
- Skin‐sensitization structure‐activity relationships for aldehydesContact Dermatitis, 2001
- Interleukin (IL)‐18 induces Langerhans cell migration by a tumour necrosis factor‐α‐ and IL‐1β‐dependent mechanismImmunology, 2001
- In vitro treatment of human transforming growth factor-β1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivityImmunology, 2000
- Use of the local lymph node assay for the estimation of relative contact allergenic potencyContact Dermatitis, 2000
- Contact sensitization: A new approach to risk assessmentHuman and Ecological Risk Assessment: An International Journal, 1997
- Differentiation of human dendritic cells from monocytes in vitroEuropean Journal of Immunology, 1997
- Examination of the local lymph node assay for use in contact sensitization risk assessmentFundamental and Applied Toxicology, 1992